Evidence mapPaperPMID 31110751Full record

ArticleClinical case reports2019

Euglycemic diabetic ketoacidosis in association with dapagliflozin use after gastric sleeve surgery in a patient with type II diabetes mellitus.

Iouri Banakh, Ross Kung, Sachin Gupta, Kati Matthiesson, Ravindranath Tiruvoipati

Open access · goldAbstract readCase Reports
In one paragraph

Article in Clinical case reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
1.4field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 16 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Iouri BanakhPharmacy Department Frankston Hospital Frankston Victoria Australia.ORCID https://orcid.org/0000-0002-7375-073X
Ross KungDepartment of Intensive Care Medicine Frankston Hospital Frankston Victoria Australia.
Sachin GuptaDepartment of Intensive Care Medicine Frankston Hospital Frankston Victoria Australia.
Kati MatthiessonVictorian Diabetes and Endocrine Network Malvern Victoria Australia.
Ravindranath TiruvoipatiDepartment of Intensive Care Medicine Frankston Hospital Frankston Victoria Australia.
Frankston Hospital · AUDiabetes Australia · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Sodium-glucose cotransporter 2 inhibitors (SGLT2Is) can be associated with euglycemic diabetic ketoacidosis (eDKA). Severe metabolic acidosis with extreme electrolyte abnormalities can occur with nonsignificant blood glucose elevations in SGLT2I-treated patients. Additional risk factors for eDKA include prolonged fasting, major illness, large weight loss, and reductions in insulin doses.

Indexed as

diabeteselectrolyte correctioneuglycemic diabetic ketoacidosisintensive caresodium–glucose cotransporter 2 inhibitor

Identifiers

PMID31110751
PMCPMC6509932
OpenAlexW2942041478

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.